Page last updated: 2024-10-27

flecainide and Bouillaud Disease

flecainide has been researched along with Bouillaud Disease in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"We report on a 46-year-old woman with ventricular tachycardia and ventricular fibrillation after starting antiarrhythmic drug therapy with flecainide."3.67[Arrhythmogenic effect of flecainide--treatment with i.v. magnesium]. ( Jung, W; Kamradt, T; Lüderitz, B; Manz, M; Mletzko, R; Vogel, F, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mletzko, R1
Jung, W1
Manz, M1
Kamradt, T1
Vogel, F1
Lüderitz, B1

Other Studies

1 other study available for flecainide and Bouillaud Disease

ArticleYear
[Arrhythmogenic effect of flecainide--treatment with i.v. magnesium].
    Zeitschrift fur Kardiologie, 1989, Volume: 78, Issue:9

    Topics: Electrocardiography; Female; Flecainide; Heart Valve Prosthesis; Humans; Magnesium; Middle Aged; Mit

1989